Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-16T16:22:40.875Z Has data issue: false hasContentIssue false

121 - Perineural Tumor Spread

from Section 4 - Abnormalities Without Significant Mass Effect

Published online by Cambridge University Press:  05 August 2013

Zoran Rumboldt
Affiliation:
Medical University of South Carolina
Zoran Rumboldt
Affiliation:
Medical University of South Carolina
Mauricio Castillo
Affiliation:
University of North Carolina, Chapel Hill
Benjamin Huang
Affiliation:
University of North Carolina, Chapel Hill
Andrea Rossi
Affiliation:
G. Gaslini Children's Research Hospital
Get access

Summary

Specific Imaging Findings

Perineural tumor spread (PNS) typically occurs with head and neck cancers and may be seen on CT; however, MRI is far more sensitive, especially with dedicated high-resolution images. Maxillary (V2) and mandibular (V3) divisions of the trigeminal nerve, along with the facial nerve, are most commonly involved. Typical findings are obliteration of the fat planes at skull base foramina, contrast enhancement and/or enlargement of a nerve. Replacement of the normal fluid in the Meckel's cave and cavernous sinus enlargement are frequent additional findings. Muscle denervation atrophy is an indirect sign of (V3) PNS with T2 hyperintensity and enhancement in the early, and volume loss and T1 hyperintensity in the late phase. CT may show obliteration of the fat planes, primarily the pterygopalatine fossa, and expansion of the skull base foramina. Detection of a suspicious cavernous sinus mass should prompt a search for PNS and a head and neck malignancy. False positive enhancement occurs with other conditions that disrupt the blood–nerve barrier, primarily inflammation and edema, which are commonly present following surgery and radiotherapy. In addition to inflammatory and infectious processes, such as sarcoidosis, PNS rarely occurs with intracranial neoplasms, such as meningioma.

Pertinent Clinical Information

PNS is a common and a potentially devastating complication of head and neck malignancies; it may be the only evidence of the disease. As it is initially clinically silent in about a half of patients, imaging plays a crucial role in its detection and delineation. Undiagnosed, the cancer slowly progresses and eventually results in symptoms, usually facial weakness or numbness, sometimes 10 or more years after the initial cancer treatment. Facial pain and/ or paresthesias may also occur. Imaging evidence of PNS worsens prognosis; however, surgery followed by radiation results in a high cure rate (approximately 80%). In symptomatic patients aggressive treatment results in a cure rate of less than 50%.

Type
Chapter
Information
Brain Imaging with MRI and CT
An Image Pattern Approach
, pp. 249 - 250
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Maroldi, R, Farina, D, Borghesi, A, et al. Perineural tumor spread. Neuroimaging Clin N Am 2008;18:413–29.CrossRefGoogle ScholarPubMed
2. Ginsberg, LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am 2002;10:511–25.CrossRefGoogle ScholarPubMed
3. Chang, PC, Fischbein, NJ, McCalmont, TH, et al. Perineural spread of malignant melanoma of the head and neck: clinical and imaging features. AJNR 2004;25:5–11.Google ScholarPubMed
4. Hanna, E, Vural, E, Prokopakis, E, et al. The sensitivity and specificity of high-resolution imaging in evaluating perineural spread of adenoid cystic carcinoma to the skull base. Arch Otolaryngol Head Neck Surg 2007;133:541–5.CrossRefGoogle ScholarPubMed
5. Gandhi, MR, Panizza, B, Kennedy, D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing “targeted” MRI with the histologic findings following surgery. Head Neck 2011;33:469–75CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×